🚀 VC round data is live in beta, check it out!
Australian Clinical Labs Valuation Multiples
Discover revenue and EBITDA valuation multiples for Australian Clinical Labs and similar public comparables like Healius, Eurobio Scientific, Frontage Laboratories, Atrys Health and more.
Australian Clinical Labs Overview
About Australian Clinical Labs
Australian Clinical Labs is Australia’s third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well established in the states of Western Australia, South Australia, Victoria, and the Northern Territory.
Founded
2016
HQ
Employees
4.7K
Website
Financials (LTM)
EV
$490M
Australian Clinical Labs Financials
Australian Clinical Labs reported last 12-month revenue of $521M and EBITDA of $141M.
In the same LTM period, Australian Clinical Labs generated $285M in gross profit, $141M in EBITDA, and $23M in net income.
Revenue (LTM)
Australian Clinical Labs P&L
In the most recent fiscal year, Australian Clinical Labs reported revenue of $527M and EBITDA of $135M.
Australian Clinical Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $521M | XXX | $527M | XXX | XXX | XXX |
| Gross Profit | $285M | XXX | $435M | XXX | XXX | XXX |
| Gross Margin | 55% | XXX | 83% | XXX | XXX | XXX |
| EBITDA | $141M | XXX | $135M | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 26% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $23M | XXX | $23M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | — | — | $15M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Australian Clinical Labs Stock Performance
Australian Clinical Labs has current market cap of $281M, and enterprise value of $490M.
Market Cap Evolution
Australian Clinical Labs' stock price is $1.50.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $490M | $281M | 0.2% | XXX | XXX | XXX | $0.12 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAustralian Clinical Labs Valuation Multiples
Australian Clinical Labs trades at 0.9x EV/Revenue multiple, and 3.5x EV/EBITDA.
EV / Revenue (LTM)
Australian Clinical Labs Financial Valuation Multiples
As of April 18, 2026, Australian Clinical Labs has market cap of $281M and EV of $490M.
Equity research analysts estimate Australian Clinical Labs' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Australian Clinical Labs has a P/E ratio of 12.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $281M | XXX | $281M | XXX | XXX | XXX |
| EV (current) | $490M | XXX | $490M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 3.5x | XXX | 3.6x | XXX | XXX | XXX |
| EV/EBIT | 10.7x | XXX | 10.9x | XXX | XXX | XXX |
| EV/Gross Profit | 1.7x | XXX | 1.1x | XXX | XXX | XXX |
| P/E | 12.4x | XXX | 12.1x | XXX | XXX | XXX |
| EV/FCF | 5.6x | XXX | 3.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Australian Clinical Labs Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Australian Clinical Labs Margins & Growth Rates
Australian Clinical Labs' revenue in the last 12 month grew by 5%.
Australian Clinical Labs' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Australian Clinical Labs' rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Australian Clinical Labs' rule of X is 32% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Australian Clinical Labs Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | 6% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 29% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | 45% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 74% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Australian Clinical Labs Public Comps
See public comps and valuation multiples for other Laboratory Services and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Eurobio Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| Frontage Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| Atrys Health | XXX | XXX | XXX | XXX | XXX | XXX |
| 908 Devices | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Australian Clinical Labs M&A Activity
Australian Clinical Labs acquired XXX companies to date.
Last acquisition by Australian Clinical Labs was on XXXXXXXX, XXXXX. Australian Clinical Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Australian Clinical Labs
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAustralian Clinical Labs Investment Activity
Australian Clinical Labs invested in XXX companies to date.
Australian Clinical Labs made its latest investment on XXXXXXXX, XXXXX. Australian Clinical Labs invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Australian Clinical Labs
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Australian Clinical Labs
| When was Australian Clinical Labs founded? | Australian Clinical Labs was founded in 2016. |
| Where is Australian Clinical Labs headquartered? | Australian Clinical Labs is headquartered in Australia. |
| How many employees does Australian Clinical Labs have? | As of today, Australian Clinical Labs has over 4K employees. |
| Who is the CEO of Australian Clinical Labs? | Australian Clinical Labs' CEO is Melinda McGrath. |
| Is Australian Clinical Labs publicly listed? | Yes, Australian Clinical Labs is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Australian Clinical Labs? | Australian Clinical Labs trades under ACL ticker. |
| When did Australian Clinical Labs go public? | Australian Clinical Labs went public in 2021. |
| Who are competitors of Australian Clinical Labs? | Australian Clinical Labs main competitors are Healius, Eurobio Scientific, Frontage Laboratories, Atrys Health. |
| What is the current market cap of Australian Clinical Labs? | Australian Clinical Labs' current market cap is $281M. |
| What is the current revenue of Australian Clinical Labs? | Australian Clinical Labs' last 12 months revenue is $521M. |
| What is the current revenue growth of Australian Clinical Labs? | Australian Clinical Labs revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Australian Clinical Labs? | Current revenue multiple of Australian Clinical Labs is 0.9x. |
| Is Australian Clinical Labs profitable? | Yes, Australian Clinical Labs is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Australian Clinical Labs? | Australian Clinical Labs' last 12 months EBITDA is $141M. |
| What is Australian Clinical Labs' EBITDA margin? | Australian Clinical Labs' last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Australian Clinical Labs? | Current EBITDA multiple of Australian Clinical Labs is 3.5x. |
| What is the current FCF of Australian Clinical Labs? | Australian Clinical Labs' last 12 months FCF is $87M. |
| What is Australian Clinical Labs' FCF margin? | Australian Clinical Labs' last 12 months FCF margin is 17%. |
| What is the current EV/FCF multiple of Australian Clinical Labs? | Current FCF multiple of Australian Clinical Labs is 5.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.